2(1H)-Quinolinone,7-[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butoxy]-3,4-dihydro-;7-[4-[4-(benzothiophen-4-yl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-qChemicalbookuinolin-2-one;BrexpiprazoleImpurity87-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one;BrexpiprazoleDimerImpurity51
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Brexpiprazole Impurity refers to <strong>chemical by-products</strong> or <strong>degradation products</strong> formed during the synthesis of the antipsychotic drug Brexpiprazole. These substances are critical for quality control in pharmaceutical manufacturing. The molecular formula and CAS number vary depending on the specific impurity profile (e.g., related compounds).</p>
<h3>Application</h3>
<ul>
<li><strong>Quality Control:</strong> Used as reference standards to validate HPLC methods for drug purity.</li>
<li><strong>R&D:</strong> Studied to identify degradation pathways under stress conditions.</li>
<li><strong>Regulatory Compliance:</strong> Essential for meeting ICH guidelines on impurity thresholds in APIs.</li>
</ul>
<h3>Precautions</h3>
<p>Store in a cool, dry place away from light and moisture. Handle with appropriate PPE to avoid skin contact or inhalation. Strictly controlled for clinical use; not intended for direct therapeutic administration.</p>